This is a commonly reported phenomenon and there are several potential explanations:
- Improved insulin sensitivity: Tirzepatide dramatically reduces insulin resistance. Hyperinsulinemia is associated with fatigue and brain fog. As insulin levels normalize, many patients report improved mental clarity and energy.
- GIP receptor effects: Unlike pure GLP-1 agonists, GIP has receptors in the CNS that may modulate energy expenditure and perceived energy. This is still being researched but early data from rodent models suggests GIP signaling in the hypothalamus affects activity levels.
- Reduced systemic inflammation: Excess adiposity drives chronic low-grade inflammation (elevated IL-6, TNF-α, CRP). As patients lose weight and visceral fat decreases, inflammatory markers drop, and patients often report feeling "better" in a general sense.
- Better sleep: Weight loss (even 5-10%) can dramatically improve sleep quality, particularly if there was undiagnosed or subclinical sleep apnea. Better sleep = more daytime energy.
- Dietary quality: As mentioned above — many patients naturally shift toward higher-quality foods because the volume reduction on tirz makes them more selective. Better nutrition → better energy.
If the energy feels excessive, disruptive to sleep, or is accompanied by racing thoughts or impulsive behavior, mention it to your prescriber to rule out other causes. But what you're describing sounds like a positive therapeutic response.
— Board-certified endocrinologist
Last edited: Jul 2, 2025 at 5:20 AM